DexCom
DXCM
Collegium Pharmaceutical
COLL
Lantheus
LNTH
Cars.com
CARS
YETI Holdings
YETI
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -129.30%-18.93K | 75.16%-52.27K | 46.01%-67.85K | 77.25%-227.23K | 396.60%44.26K | 112.67%64.62K | -152.23%-210.44K | 85.67%-125.67K | -472.95%-998.71K | 15.42%-14.92K |
Net income from continuing operations | 49.85%-360.99K | -6.28%920.09K | 11.35%-1.07M | -43.24%-1.66M | 35.31%-711.09K | -189.14%-719.84K | 68.87%981.73K | -209.25%-1.21M | 17.37%-1.16M | -2,730.48%-1.1M |
Operating gains losses | -86.01%90.56K | 13.89%-1.16M | -25.49%779.97K | 19.69%716.07K | -65.88%367.44K | --647.1K | -1,574.26%-1.35M | 283.65%1.05M | 36.47%598.27K | 276.80%1.08M |
Depreciation and amortization | 848.72%126.02K | 1,093.33%136.65K | 1,083.54%136.14K | 229.55%300.64K | 2,209.16%264.4K | -36.16%13.28K | -61.16%11.45K | -60.99%11.5K | -23.13%91.23K | -61.17%11.45K |
Other non cash items | --1.28K | --44.68K | ---6.53K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Change In working capital | 59.39%124.21K | -96.67%4.72K | 274.47%94.52K | 173.13%387.88K | 155.69%143.01K | 123.27%77.92K | 143.97%141.71K | -64.32%25.24K | -690.96%-530.42K | 212.17%55.93K |
-Change in prepaid assets | --0 | ---- | ---- | --0 | -450.00%-175K | --0 | ---- | ---- | ---625K | --50K |
-Change in payables and accrued expense | 102.42%157.73K | 114.18%4.72K | 274.47%94.52K | 310.10%387.88K | 5,376.36%318.01K | 506.92%77.92K | -1,312.90%-33.29K | -65.51%25.24K | 257.12%94.58K | 105.13%5.81K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -129.30%-18.93K | 75.16%-52.27K | 46.01%-67.85K | 77.25%-227.23K | 168.17%44.26K | 114.05%64.62K | 44.50%-210.44K | -32.82%-125.67K | -472.95%-998.71K | -267.98%-64.92K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.02K | 0 |
Net PPE purchase and sale | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---4.02K | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---4.02K | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 125.79%19.06K | -76.21%52.27K | -46.24%67.85K | -77.34%227.23K | -165.24%-44.82K | -117.16%-73.88K | -45.39%219.73K | 24.84%126.2K | 504.92%1M | 289.40%68.7K |
Net issuance payments of debt | -107.33%-25.04K | 97.24%-3.89K | 154.04%109.17K | -80.31%174.44K | -333.05%-69.7K | -23.34%341.79K | -134.30%-140.63K | --42.97K | --885.77K | --29.91K |
Net common stock issuance | --15.7K | --0 | --0 | -64.27%35K | ---- | ---- | --374.7K | -41.67%35K | --97.97K | --42.74K |
Net other financing activities | -1,416.92%-90.64K | 491.55%56.16K | -185.68%-41.33K | -6.31%17.79K | -15.97%-10.12K | -4.44%-5.98K | -87.33%-14.34K | 17.36%48.23K | -88.54%18.99K | -149.48%-8.73K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 125.79%19.06K | -76.21%52.27K | -46.24%67.85K | -77.34%227.23K | -170.12%-44.82K | -116.97%-73.88K | -45.39%219.73K | 24.84%126.2K | 504.92%1M | 262.31%63.92K |
Net cash flow | ||||||||||
Beginning cash position | --0 | --0 | --0 | --0 | -43.70%563 | -61.65%9.83K | -96.48%228 | ---306 | --0 | --1K |
Current changes in cash | ---- | ---- | ---- | ---- | ---- | 62.38%-9.26K | -51.47%9.29K | -91.76%534 | ---- | ---- |
End cash Position | -77.80%125 | --0 | --0 | --0 | --0 | -43.70%563 | -61.65%9.83K | -96.48%228 | --0 | --0 |
Free cash flow | -129.30%-18.93K | 75.16%-52.27K | 46.01%-67.85K | 77.34%-227.23K | 168.17%44.26K | 114.05%64.62K | 45.08%-210.44K | -32.82%-125.67K | -475.26%-1M | -267.98%-64.92K |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |